Chen Jie
Founding Partner @ BioVenture
Chen Jie is a seed investor at BioVenture focused on Medical and Health Care. Chen Jie
- Total investments:
- 5
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Chen Jie invests in
Stages Chen Jie invests in
Countries Chen Jie invests in
Investment Focus
Industry
- Medical 4 (80%)
- Health Care 3 (60%)
- Biopharma 2 (40%)
- Biotechnology 2 (40%)
- Training 1 (20%)
Stage
- Seed 2 (40%)
- Series A 2 (40%)
- Series B 1 (20%)
Country
- China 4 (80%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xiaolu Biotech
|
Xiaolu Bio is a biopharmaceutical developer that focuses on the research and development of innovative drugs for autoimmune and inflammatory diseases. | Seed / Jun 17, 2025 | |
|
Sanegene Bio
|
Sanegene Bio is currently operating in stealth mode. | $80M / Series A / Dec 01, 2023 | |
Ruoyi Biotech
|
Ruoyi Biotech is a developer of macromolecular drug delivery technology. | Seed / Mar 18, 2023 | |
Reforgene Medicine
|
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases. | Series A / Sep 16, 2021 | |
Dami&Xiaomi
|
Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, andpopular science information. | $13.6M / Series B |
Co-Investors
Oriza Holdings
2 deals together
Alwin Capital
1 deal together
BioTrack Capital
1 deal together
China Merchants Securities
1 deal together
Dongjiu Xinyi Capital
1 deal together
About BioVenture
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
BioVenture Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Erik Hoppe
Executive Partner
|
|||
|
Chen Jie
Founding Partner
|
|||
Gaojian Ning
Investment Director
|
|||
Haihua Huang
Investment Director
|
|||
Jacky Chen
General Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Chen Jie invest in?
Chen Jie invests primarily in Medical, Health Care and Biopharma startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chen Jie last invest?
The most recent investment recorded for Chen Jie closed in Jun 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
